Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib in Fibromyalgia
NCT00755521Phase 4Unknown
- Sponsor
- Meir Medical Center
- Start
- Sep 2008
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in fibromyalgia (FM) comparing Etoricoxib with Placebo (2 arms). Primary endpoint: Brief Pain Inventory at 6 weeks. Status: unknown.
02
Drugs
etoricoxib
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00755521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00755521.